UniProt ID | PELP1_MOUSE | |
---|---|---|
UniProt AC | Q9DBD5 | |
Protein Name | Proline-, glutamic acid- and leucine-rich protein 1 | |
Gene Name | Pelp1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1123 | |
Subcellular Localization | Nucleus, nucleolus . Nucleus, nucleoplasm . Nucleus . Cytoplasm . Mainly found in the nucleoplasm, with low levels detected in the cytoplasm. Also found associated with the plasma membrane. | |
Protein Description | Coactivator of estrogen receptor-mediated transcription and a corepressor of other nuclear hormone receptors and sequence-specific transcription factors. Plays a role in estrogen receptor (ER) genomic activity when present in the nuclear compartment by activating the ER target genes in a hormonal stimulation dependent manner. Can facilitate ER non-genomic signaling via SRC and PI3K interaction in the cytosol. Plays a role in E2-mediated cell cycle progression by interacting with RB1. May have important functional implications in ER/growth factor cross-talk. Interacts with several growth factor signaling components including EGFR and HRS. Involved in nuclear receptor signaling via its interaction with AR and NR3C1. May promote tumorigenesis via its interaction with and modulation of several oncogenes including SRC, PI3K, STAT3 and EGFR. Plays a role in cancer cell metastasis via its ability to modulate E2-mediated cytoskeleton changes and cell migration via its interaction with SRC and PI3K (By similarity). Functions as the key stabilizing component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes. [PubMed: 22872859 Component of the PELP1 complex involved in the nucleolar steps of 28S rRNA maturation and the subsequent nucleoplasmic transit of the pre-60S ribosomal subunit. Regulates pre-60S association of the critical remodeling factor MDN1 (By similarity] | |
Protein Sequence | MAAAVLSGASAGSPAGAPGGPGGLSAVGSGPRLRLLLLESISGLLQPRTASPVAPVHPPIQWAPHLPGLMCLLRLHGTAGGAQNLSALGALVNLSNAHLGSIKTRFEGLCLLSLLIGESPTELFQQHCVSWLRSIQQVLQSQDSPSTMELAVAVLRDLLRHASQLPTLFRDISTNHLPGLLTSLLGLRPECEQSALEGMKACVTYFPRACGSLKGKLASFFLSRLDSLNPQLQQLACECYSRLPSLGAGFSQGLKHTENWEQELHSLLTSLHSLLGSLFEETEPAPVQSEGPGIEMLLSHSEDGNTHVLLQLRQRFSGLARCLGLMLSSEFGAPVSVPVQEILDLICRILGISSKNINLLGDGPLRLLLLPSLHLEALDLLSALILACGSRLLRFGALISRLLPQVLNAWSTGRDTLAPGQERPYSTIRTKVYAILELWVQVCGASAGMLQGGASGEALLTHLLSDISPPADALKLCSTRGSSDGGLQSGKPSAPKKLKLDMGEALAPPSQRKGDRNANSDVCAAALRGLSRTILMCGPLIKEETHRRLHDLVLPLVMSVQQGEVLGSSPYNSSCCRLGLYRLLLALLLAPSPRCPPPLACALKAFSLGQWEDSLEVSSFCSEALVTCAALTHPRVPPLQSSGPACPTPAPVPPPEAPSSFRAPAFHPPGPMPSIGAVPSTGPLPSAGPIPTVGSMASTGQVPSRPGPPATANHLGLSVPGLVSVPPRLLPGPENHRAGSGEDPVLAPSGTPPPSIPPDETFGGRVPRPAFVHYDKEEASDVEISLESDSDDSVVIVPEGLPSLPPAPPSGTPPPAAPAGPPTASPPVPAKEDSEELPATPGPPPPPPPPPPPASGPVTLPPPQLVPEGTPGGGGPTAMEEDLTVININSSDEEEEEEEEEEEEDEDEEEEDFEEEEEDEEEYFEEEEEEEEFEEEFEEEEGELEEEEEEEEEELDEVEDVEFGSAGEVEEGGPPPPTLPPALPPSDSPKVQPEAEPEPGLLLEVEEPGPEEVPGPETAPTLAPEVLPSQEEGEQEVGSPAAGPPQELVEESSAPPALLEEGTEGGGDKVPPPPETPAEEMETEAEVPAPQEKEQDDTAAMLADFIDCPPDDEKPPPATEPDS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAAVLSGA ------CCCHHHCCC | 18.55 | 19131326 | |
7 | Phosphorylation | -MAAAVLSGASAGSP -CCCHHHCCCCCCCC | 26.22 | 26824392 | |
10 | Phosphorylation | AAVLSGASAGSPAGA CHHHCCCCCCCCCCC | 36.37 | 27566939 | |
13 | Phosphorylation | LSGASAGSPAGAPGG HCCCCCCCCCCCCCC | 15.99 | 26824392 | |
25 | Phosphorylation | PGGPGGLSAVGSGPR CCCCCCHHCCCCCHH | 24.96 | 25619855 | |
29 | Phosphorylation | GGLSAVGSGPRLRLL CCHHCCCCCHHHHHH | 38.74 | 25619855 | |
49 | Phosphorylation | SGLLQPRTASPVAPV HHCCCCCCCCCCCCC | 37.86 | 26745281 | |
51 | Phosphorylation | LLQPRTASPVAPVHP CCCCCCCCCCCCCCC | 21.21 | 26745281 | |
478 | Phosphorylation | ADALKLCSTRGSSDG HHHHHHHCCCCCCCC | 31.41 | 26643407 | |
479 | Phosphorylation | DALKLCSTRGSSDGG HHHHHHCCCCCCCCC | 37.74 | 26643407 | |
482 | Phosphorylation | KLCSTRGSSDGGLQS HHHCCCCCCCCCCCC | 23.20 | 28833060 | |
483 | Phosphorylation | LCSTRGSSDGGLQSG HHCCCCCCCCCCCCC | 43.00 | 28833060 | |
489 | Phosphorylation | SSDGGLQSGKPSAPK CCCCCCCCCCCCCCC | 54.55 | 28833060 | |
510 | Phosphorylation | GEALAPPSQRKGDRN CHHCCCHHHCCCCCC | 41.37 | 29895711 | |
648 | Phosphorylation | SSGPACPTPAPVPPP CCCCCCCCCCCCCCC | 31.78 | 22006019 | |
740 | Phosphorylation | PENHRAGSGEDPVLA CCCCCCCCCCCCCCC | 37.72 | 22942356 | |
749 | Phosphorylation | EDPVLAPSGTPPPSI CCCCCCCCCCCCCCC | 50.09 | 26824392 | |
751 | Phosphorylation | PVLAPSGTPPPSIPP CCCCCCCCCCCCCCC | 36.64 | 27087446 | |
755 | Phosphorylation | PSGTPPPSIPPDETF CCCCCCCCCCCCCCC | 54.20 | 25521595 | |
761 | Phosphorylation | PSIPPDETFGGRVPR CCCCCCCCCCCCCCC | 34.65 | 25619855 | |
1029 | Phosphorylation | LAPEVLPSQEEGEQE CCCCCCCCCCCCCCC | 46.17 | - | |
1039 | Phosphorylation | EGEQEVGSPAAGPPQ CCCCCCCCCCCCCCH | 19.28 | - | |
1053 | Phosphorylation | QELVEESSAPPALLE HHHHHHCCCCCHHHC | 48.34 | - | |
1076 | Phosphorylation | KVPPPPETPAEEMET CCCCCCCCCHHHHCC | 33.31 | 25338131 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
751 | T | Phosphorylation | Kinase | GSK3B | Q9WV60 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PELP1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PELP1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of PELP1_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |
"Phosphoproteomic analysis of the developing mouse brain."; Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.; Mol. Cell. Proteomics 3:1093-1101(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-751, AND MASSSPECTROMETRY. |